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Abstract
Apoptosis is a highly regulated form of programmed cell death, essential to the development and homeostasis of
multicellular organisms. Cytochrome c is a central figure in the activation of the apoptotic intrinsic pathway, thereby
activating the caspase cascade through its interaction with Apaf-1. Our recent studies have revealed 14-3-3ε (a direct
inhibitor of Apaf-1) as a cytosolic cytochrome c target. Here we explore the cytochrome c / 14-3-3ε interaction and
show the ability of cytochrome c to block 14-3-3ε-mediated Apaf-1 inhibition, thereby unveiling a novel function for
cytochrome c as an indirect activator of caspase-9/3. We have used calorimetry, NMR spectroscopy, site mutagenesis
and computational calculations to provide an insight into the structural features of the cytochrome c / 14-3-3ε
complex. Overall, these findings suggest an additional cytochrome c-mediated mechanism to modulate apoptosome
formation, shedding light onto the rigorous apoptotic regulation network.
Introduction
Apoptosis, a specific form of programmed cell death
(PCD), is an essential process for development and
homeostasis of multicellular organisms1. There are two
main apoptotic pathways in mammalian cells: the
extrinsic or death receptor-initiated pathway and the
intrinsic or mitochondria-dependent pathway2,3. The last
is triggered by signals, including DNA damage, oxidative
stress, and growth factor deprivation, which converge on
the release of pro-apoptotic proteins from the mito-
chondria into the cytosol; one such protein is cytochrome
c (Cc). Under homeostasis, Cc acts as an electron carrier
in the mitochondrial respiratory chain4,5. Upon its release
from mitochondria, Cc interacts with WD40 domains of
the apoptotic protease activating factor-1 (Apaf-1) in the
cytosol, enabling the assembly of the apoptosome6. This
protein platform activates caspase-9 and later caspase-3,
initiating the caspase cascade, which executes cell death in
an orchestrated way7,8.
Recent findings suggest Cc fulfills multiple roles in
apoptosis, beyond Apaf-1 activation and apoptosome
assembly. Indeed, Cc interacts with various cytosolic and
nuclear partners along the onset of PCD9,10. Hence, the
full scope of Cc role in apoptosis remains un-elucidated.
Recently, our group has reported that Cc inhibits the
histone chaperone activity of SET/TAF-Iβ in the nucleus,
impairing the formation of core histone-SET/TAF-Iβ
complexes under DNA damage11. However, the novel
functions of cytosolic Cc stay unveiled, despite a complex
network of interactions mediated by Cc during apoptosis
has been suggested12.
Therefore, we focused on the interaction between Cc
and protein 14-3-3ε, a novel cytosolic Cc target under
DNA damage10. This protein belongs to the 14-3-3
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family13,14, which comprises seven conserved isoforms (β,
γ, ε, η, σ, τ/θ, and ζ), arranged as homo- and heterodimers.
Each monomer contains nine α-helices that form a con-
served concave groove, used by 14-3-3 proteins to bind
their phosphorylated targets15 (Supplementary Figure S1).
Furthermore, they are also involved in phosphorylation-
independent interactions16–18. 14-3-3 proteins participate
in several cell processes related to metabolism, signal
transduction, cell cycle control, apoptosis, transcription,
and stress responses19–24.
Among 14-3-3ε functions, its ability to inhibit Apaf-1
stands out because it prevents apoptosome assembly and
caspase activation25. Such inhibition is enhanced by
phosphorylation of Apaf-1 at Ser268 by the p90kDa
ribosomal S6 kinase-1 (Rsk-1) when the mitogen-
activated protein kinases (MAPK) cascade is active.
Hence, the interaction of Cc with 14-3-3ε could modulate
such inhibition somehow.
Herein, we show that Cc hinders 14-3-3ε-mediated
Apaf-1 inhibition. Indeed, our results indicate a compe-
tition between Cc and 14-3-3ε for binding to Apaf-1,
which enhances caspase activation. Furthermore, this
new regulatory mechanism is modulated by phosphor-
ylation of Apaf-1, which enhances its inhibition by 14-3-
3ε. We further show that Cc binds to both the 14-3-3ε
concave groove and the convex face, thereby providing a
molecular basis for this novel modulation of apoptosome
assembly.
Results
Cc interacts with 14-3-3ε in the cytosol under apoptotic
conditions
To elucidate the extra-mitochondrial function of Cc, we
explored the interaction of Cc with 14-3-3ε when apop-
tosis is triggered. To this aim, HeLa cells were treated
with the topoisomerase I inhibitor camptothecin (CPT),
to induce DNA damage. Then, subcellular fractionation
was performed, and Cc was detected in the cytosol
(Fig. 1a, lane 3). However, it remained inside the mito-
chondria under homeostasis (Fig. 1a, lane 2). The in cell
Cc / 14-3-3ε interaction was established as immunopre-
cipitation (IP) of cytosolic proteins associated with Cc
yielded intrinsic 14-3-3ε in CPT-treated cells (Fig. 1b, lane
6). To further confirm the IP specificity, untreated and
CPT-treated cytosolic lysates were probed with a 14-3-3ε
antibody (Fig. 1b, lanes 1 and 4, respectively). Negative
controls using IgG (Fig. 1b, lanes 2 and 5) did not display
any band. Immunoblotting against the anti-Cc antibody
confirmed Cc IP (Fig. 1b, lane 6).
Cc blocks 14-3-3ε-mediated caspase inhibition
Following its release into the cytosol, Cc targets Apaf-1
to assemble the apoptosome6. As 14-3-3ε binds Apaf-1 to
prevent caspase activation25, we investigated whether Cc
modulates Apaf-1 inhibition by 14-3-3ε.
First, we checked the ability of Cc to activate caspase-3
in HEK293T cytosolic cell extracts. Caspase-3 activity was
monitored upon Cc addition (Fig. 2a, white columns),
resulting in a substantial increase of such activity, as the
hemeprotein triggered the apoptosome formation and,
subsequently, caspase-9, -3 activation.
MAPK proteins modulate Apaf-1 activity, leading the
activation of Rsk-1, which phosphorylates Apaf-1 at
Ser268, favoring the interaction between Apaf-1 and 14-3-
3ε, thereby increasing Apaf-1 inhibition25. Therefore, we
tested the effect of phorbol 12-myristate 13-acetate
(PMA), which triggers the MAPK cascade, on the caspase-
3 activity. Apaf-1 phosphorylation under PMA treatment
was confirmed by Phos-tagTM SDS PAGE (Supplementary
Figure S2). PMA-treated cells extracts showed a lower
caspase-3 activity than untreated extracts in the presence
of Cc (Fig. 2a, gray columns). This is consistent with Apaf-
1 phosphorylation at Ser268, enhancing its inhibition by
14-3-3ε25.
Fig. 1 Cc localization in the cytosol upon cell CPT-treatment. a Subcellular fractioning showing the Cc location upon cell treatment with 20 μM
CPT for 4 h. Purity of fractions was verified by western blot using anti-α-Tubulin and anti-CoxIV antibodies for detecting cytosolic and membrane
proteins, respectively. b Cc-IP of cytosolic fractions from non-treated (lane 3) and CPT-treated (lane 6) along with the detection of 14-3-3ε by western
blot (upper). Mouse IgG was used as control (lanes 2 and 5). Verification of immunoprecipitation of Cc upon CPT treatment is shown (lower)
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Then, we tested the ability of recombinant 14-3-3ε
(herein named as 14-3-3ε full length, 14-3-3ε FL) to
inhibit caspase-3 activity in non-treated and PMA-treated
cell extracts. Addition of 14-3-3ε FL made extracts to
exhibit significantly lower Cc-mediated caspase-3 activity
values (Fig. 2a). These were normalized to identify the
particular effect of added 14-3-3ε FL but, unexpectedly,
the normalization evinced that the inhibition exerted by
14-3-3ε FL was similar in non-treated and PMA-treated
extracts (Fig. 2b). One of the plausible explanations for
this observation is endogenous 14-3-3ε already abolished
the caspase-3 activity by preferentially binding to phos-
phorylated Apaf-1, thus preventing any additional effect
of exogenous 14-3-3ε FL. Additional caspase-3 assays
were carried out using extracts from 14-3-3ε knockdown
HEK293T cells (Fig. 2c), with the caspase-3 activity in
PMA-treated extracts resulting more sensitive than non-
treated extracts to the addition of 14-3-3ε FL (Fig. 2d).
In summary, these findings demonstrate how 14-3-3ε
FL inhibits caspase activity, and how this inhibitory
mechanism can be modulated by Apaf-1 phosphorylation.
Nevertheless, the inhibitory effect of 14-3-3ε FL on
caspase-3 could be caused by either a direct interaction
with Apaf-1 or by hindering the complex between the
latter and Cc. Caspase-9 can indeed be phosphorylated by
the ERK MAPK pathway, with the resulting modulation of
its function and consequently, of caspase-3 activation26.
To discard the direct interaction between Cc and Apaf-
1, as well as the ERK-mediated inhibition of caspase-9, we
performed caspase-9 activity assays using a recombinant,
truncated form of Apaf-1 lacking the Cc-binding WD40
domains (Apaf-1ΔWD40)
27. Apaf-1ΔWD40 activates caspase-
9 in a constitutive manner in the absence of Cc (Fig. 3).
The inability of Cc to alter the Apaf-1ΔWD40-mediated
caspase-9 activity was likewise determined (Supplemen-
tary Figure S3). Then, the addition of 14-3-3ε FL inhibited
caspase-9 activity strongly, due to the binding of Apaf-
1ΔWD40 to 14-3-3ε FL (Fig. 3). However, the sequentially
titration with Cc restored caspase-9 activity, indicating a
competition between Cc and Apaf-1ΔWD40 for the binding
Fig. 2 14-3-3ε FL inhibits caspase-3 activity in HEK293T cytosolic cell extracts. a Relative caspase-3 activity in non-treated (white columns) and
PMA-treated (gray columns) HEK293T cytosolic cell extracts were measured upon addition of recombinant Cc and increasing concentrations of 14-3-
3ε FL. b Normalized data shown in a. c HEK293T cells were transfected with empty pSUPER (Control) or with pSUPER-shRNA against 14-3-3ε and
immunoblotted with an anti-14-3-3ε antibody to examine the amount of remaining endogenous 14-3-3ε. An immunoblotting with anti-α-tubulin
was used as loading control. d Normalized caspase-3 activity in 14-3-3ε-silenced non-treated and PMA-treated cell extracts upon addition of
recombinant 14-3-3ε FL. Normalized caspase-3 activity of non-14-3-3ε-silenced, non-treated cell extracts is included as a control
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site of 14-3-3ε FL, impairing Apaf-1 inhibition. Nuclear
magnetic resonance (NMR) experiments corroborated
such a competition. Specifically, the ε-methyl group signal
of Met80 in reduced Cc substantially broadened upon
binding of the hemeprotein to 14-3-3ε (Supplementary
Figure S3e). Further addition of Apaf-1ΔWD40 yielded
partial recover of the signal intensity, indicating that
Apaf-1ΔWD40 competes with Cc for the 14-3-3ε FL bind-
ing site. The inability of Apaf-1ΔWD40 to bind Cc was
corroborated (Supplementary Figure S3f).
As phosphorylation of Apaf-1 at Ser268 enhances its
interaction with 14-3-3ε FL, we tested the ability of Cc to
modulate the 14-3-3ε FL / Apaf-1ΔWD40 complex upon
phosphorylation. To this end, we designed the recombi-
nant Apaf-1ΔWD40 S268D mutant, which mimics Ser268
phosphorylation. As a control of unspecific effects caused
by mutations at such position, the Apaf-1ΔWD40 S268A
variant was also tested. Notably, the ability of phospho-
mimetic Apaf-1ΔWD40 S268D mutant to trigger caspase-9
activity was similar to that exhibited by Apaf-1ΔWD40.
Nevertheless, the Apaf-1ΔWD40 S268D-mediated caspase-
9 activity was slightly more sensitive to 14-3-3ε (Fig. 3,
gray columns). Indeed, the recovery of enzymatic activity
by Cc was substantially lower than that measured using
Apaf-1ΔWD40 (Fig. 3, gray columns). Such a finding indi-
cates a larger affinity of the phosphorylated Apaf-1 species
toward 14-3-3ε that displaces Cc25. On the other hand,
the caspase-9 activation in the presence of the S268A
mutant behaved in a way similar to that in the presence of
Apaf-1ΔWD40 (Supplementary Figure S3b). Hence, the
negative charge at position 268 in Apaf-1 is responsible
for the increase in affinity of Apaf-1 toward 14-3-3ε FL.
Our results thus support a model in which Cc activates
Apaf-1 while blocking the inhibition exerted by 14-3-3ε
on the apoptotic factor (Fig. 4).
Cc recognizes two different binding sites of 14-3-3ε full
length
The dimerization state of 14-3-3ε FL was confirmed by
analytic ultracentrifugation combined with dynamic light
scattering (Supplementary Figure S4a-c). Sedimentation
velocity experiments confirmed the dimeric state of 14-3-
3ε FL with a molecular mass of 66.4 kDa (Supplementary
Figure S4b). Dynamic light scattering measurements
corroborated that 14-3-3ε FL behaves as a dimer, with a
particle size of 9 ± 2 nm (Supplementary Figure S4c).
Isothermal titration calorimetry (ITC) experiments in
Supplementary Figure S5 revealed that Cc binds to 14-3-
3ε FL homodimer with a 2:1 stoichiometry and a dis-
sociation constant (KD) of 2.3 μM (Supplementary
Table S1). To reveal 14-3-3ε residues implicated in the
interaction with Cc, 14-3-3ε FL D21K, K50E, S59E, E92K,
D99K, and S187D mutants were designed. Residues were
selected according to their role in the interactions of 14-3-
3 isoforms with their respective partners28–30 and the
impact of each mutation in the electrostatic surface
potential of the protein. The dimeric state of these
mutants was confirmed by analytic ultracentrifugation
and dynamic light scattering (Supplementary Figure S4c
and d). According to ITC analysis (Supplementary
Table S1 and Figure S5), the six mutants bound to Cc with
slightly larger KD values than 14-3-3ε FL WT. Further, the
complexes involving 14-3-3ε FL D21K, K50E, S59E, or
E92K showed a 1:1 stoichiometry instead of the 2:1 found
for the WT species (Supplementary Table S1), suggesting
that one of the two Cc-binding sites of 14-3-3ε FL has
been compromised in these mutants. Therefore, Asp21,
Lys50, Ser59, and Glu92 residues may be essential in Cc
recognition.
We also performed NMR experiments to further char-
acterize the interaction between reduced Cc and 14-3-3ε
FL. We followed Cc signals upon titration of 14-3-3ε FL,
which caused an overall broadening of Cc resonances
Fig. 3 Cc impairs 14-3-3ε FL-mediated caspase-9 inhibition. Cc
and 14-3-3ε FL were added to caspase-9 and different Apaf-1ΔWD40
mutants
Fig. 4 Model of Apaf-1 regulation by Cc and 14-3-3ε. Model of
Apaf-1 regulation by Cc and 14-3-3ε. During homeostasis, Apaf-1 is
available to interact with 14-3-3ε25. Upon its release into the cytosol,
Cc competes with Apaf-1 for the binding to 14-3-3ε, impairing the
Apaf-1 / 14-3-3ε complex. Thus, Apaf-1 is available to interact with Cc,
thereby activating the caspases cascade6. Upon Apaf-1
phosphorylation, the equilibrium of the reaction is strongly shifted
toward the Apaf-1 / 14-3-3ε complex formation. This would hinder the
competition performed by Cc, thereby partly impairing the activation
of the caspases
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because Cc / 14-3-3ε FL complex formation (Fig. 5a and
Supplementary Figure S6a, left). Specifically, the ε-methyl
group signal of the Met80 Cc residue was largely broa-
dened at 1:0.5 Cc:14-3-3ε FL ratio (Fig. 5a), in agreement
with the stoichiometry inferred from ITC data. Moreover,
specific Cc backbone amide groups underwent singularly
large changes in their 1H line widths (1H ΔΔν1/2 Binding)
upon binding with 14-3-3ε FL (Supplementary Fig-
ure S6b). These resonances were expected to be at or in
the proximity of the area of Cc involved in the recognition
of 14-3-3ε FL. Moreover, several signals displayed
substantial chemical-shift perturbations (CSPs) in the
presence of 14-3-3ε FL (Supplementary Figure S6a, right).
Specifically, Gln16, Thr19, Ser47, Lys72, Gly77 and
Val83 signals showed significant CSPs (Δδavg > 0.035
ppm.). Interestingly, the signal corresponding to
Val83 (Supplementary Figure S6a, right) seems to be in
conformational exchange in the free Cc, fixing its
conformation upon the interaction with 14-3-3ε.
These effects are consistent with an intermediate
exchange rate at the NMR time scale, in agreement with
the transient nature of this complex and the KD values in
the μM range.
Both broadening and CSPs maps on Cc surface (Fig. 5b)
indicate that Ccmainly recognizes 14-3-3ε FL by a surface
patch surrounding the heme cleft, as it does in its
homeostatic interactions in the electron transport
chain31–33.
The C-terminal tails of 14-3-3ε are important in the
interaction with Cc
To decipher the role of the unstructured C-terminal tail
of 14-3-3ε FL during Cc recognition, the interaction
between Cc and the 14-3-3ε core protein, lacking C-
terminal tails, was measured by ITC. The recorded ther-
mograms showed very similar thermodynamic parameters
for both 14-3-3ε FL and 14-3-3ε core proteins interacting
with Cc, although a slight increase in the KD value was
observed in the interaction between Cc and the 14-3-3ε
core (Supplementary Table S1). This suggests that the C-
terminal tails of 14-3-3ε may participate in the interaction
with Cc, despite being unessential.
To confirm that the C-terminal tails of 14-3-3ε (named
14-3-3ε234-255) are involved in the interaction with Cc, 2D
[1H, 15N] HSQC were recorded along a titration of 14-3-
3ε234-255 peptide onto
15N-labeled reduced Cc
Fig. 5 Binding of Cc to 14-3-3ε as analyzed by NMR. a 1D 1H NMR spectra of Cc (Fe2+) along the titration with 14-3-3ε FL. The complex formation
is monitored by line broadening of the Met80-εCH3 signal, included in the black square. b Mapping of the Cc residues perturbed upon binding to 14-
3-3ε FL. The Cc:14-3-3ε ratio is 1:0.75. Residues are colored according to their 1H ΔΔν1/2Binding (Supplementary Figure S6b). Residues with average
chemical-shift perturbations (Δδavg) larger than 0.035 p.p.m. are represented in orange. Asterisks stand for residues showing both significant
1H ΔΔν1/
2Binding and Δδavg. Residues without substantial
1H ΔΔν1/2Binding and Δδavg are in blue. c Detail of superimposed 2D [
1H, 15N] HSQC spectra of 15N-
labeled Cc along titration with 14-3-3ε234-255. Signals corresponding to distinct titration steps are colored according to the code in the panel. Arrow
indicates direction of CSPs. d CSP map of reduced Cc upon addition of 14-3-3ε234-255. Residues are colored according to Δδavg categories:
insignificant Δδavg < 0.020 ppm., blue; small 0.020 ppm. ≤ Δδavg < 0.025 ppm. yellow; and large Δδavg > 0.025 ppm., red. In b, d prolines and non-
assigned residues are colored in gray; whereas, the heme group in green. e 1D 19F NMR spectra of free 5-fluorindole (upper) and when it is
conjugated with 14-3-3ε234-255 peptide (lower). f 1D
19F NMR spectra of 14-3-3ε234-255 whose Lys244 is covalently bound to 5-fluorindole free and in
the titrations with Cc and BSA. 19F CSPs are colored according to the panels
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(Supplementary Figure S6c). Such titration resulted in
significant CSPs of the Cc amide signals (Fig. 5c). The
resulting interaction surface (Fig. 5d) indicates that 14-3-
3ε234-255 binds to the rim of the heme groove of Cc, as
with 14-3-3ε FL protein. However, unlike the 14-3-3ε FL
interaction, most of the Cc resonances were in fast
exchange on the NMR time scale upon binding to the 14-
3-3ε234-255 peptide.
1H Δδbind was fitted using the best 1:1
binding model, obtaining a KD of 49 μM (Supplementary
Figure S6d). Moreover, ITC experiments in which the 14-
3-3ε234-255 peptide was titrated onto Cc yielded a KD value
of 16 μM (Supplementary Figure S5 and Table S1). Both
NMR and ITC KD values are marginally higher than the
value obtained for the interaction between 14-3-3ε FL and
Cc. Furthermore, the ITC analysis also confirmed a
1:1 stoichiometry.
Then, to easily determine a residue which could be
included in the latter docking calculations, the only one
positively charged residue (Lys244) of 14-3-3ε234-255
peptide was tagged with 5-fluorindole molecule through
a conjugation reaction. To prevent the reaction of 5-
fluorindole with the N-terminal −NH3
+ group, the pep-
tide was modified by acetylation. To confirm that the
acetylation in the N-terminal residue did not drastically
modify the interaction with Cc, ITC experiments were
performed with the acetylated 14-3-3ε234-255. Both the
non-acetylated and acetylated peptides interacted with Cc
in a similar way, despite the KD value showed a slight
increase when the peptide was acetylated (Supplementary
Table S1).
Proper folding of 14-3-3ε234-255 before and after the
conjugation reaction was unambiguously assessed by 1D
1H NMR spectra (Supplementary Figure S6e). Second, 1D
19F NMR spectra of both free 5-fluorindole and fluori-
nated 14-3-3ε234-255 were registered. The spectrum of
fluorinated 14-3-3ε234-255 peptide showed a signal at
−125.53 ppm. corresponding to free 5-fluorindole, and
another at −123.62 ppm. that was assigned to 5-
fluorindole conjugated to the epsilon −NH3
+ group of
Lys244 (Fig. 5e). The addition of increasing concentration
of Cc resulted in significant CSPs of this second signal
(Fig. 5f, left panel). Notably, the 19F NMR signal also
experienced a significant broadening consistent with the
larger correlation time of the peptide bound to Cc.
As a negative control, bovine serum albumin (BSA)
protein was titrated into fluorinated 14-3-3ε234-255 pep-
tide, with the negligible resulting 19F CSPs, suggesting
that BSA cannot significantly bind to the peptide. (Fig. 5f,
right panel). These results agree with Lys244 of 14-3-3ε
FL taking part in Cc recognition. Therefore, Lys244 was
included as an active residue in further docking calcula-
tions (see below).
Structural model of the interaction between Cc and 14-3-
3ε full length
To further understand the molecular features of the
interaction between Cc and 14-3-3ε FL, we performed
restrain-driven docking computations using HADDOCK
software34. For these computations, we used the structural
model of 14-3-3ε FL in its open conformation inferred
from MD as the input structure (Supplementary Infor-
mation and Figure S7), to allow the entrance of Cc into
the concave groove of the 14-3-3ε dimer. Line widths and
CSPs obtained from NMR analysis of the Cc / 14-3-3ε FL
complex were used as Cc ambiguous interaction restrains
(AIRs). The 14-3-3ε FL residues that resulted in the
impairment of one of the Cc-binding sites by ITC were
used as 14-3-3ε AIRs. The 500 solutions obtained in the
computation showed two main Cc-binding sites on 14-3-
3ε FL dimer, in agreement with the stoichiometry inferred
from ITC data. These solutions located Cc in both the
concave and convex faces of 14-3-3ε; these interacting
regions will be referred hereafter to as the concave and
convex binding sites, respectively. The convex site resul-
ted more populated, although some of the lowest energy
solutions locate within the concave site (Fig. 6, left panel).
Statistical classification of solutions yielded three clusters
in the convex site of 14-3-3ε and only one in the concave
site (Supplementary Figure S8a). Further analyses indicate
that electrostatics is the major contributing factor to
Fig. 6 HADDOCK molecular docking of Cc and 14-3-3ε FL. Mass centers of Cc on the structural model of 14-3-3ε FL on its open conformation,
including (right) or not (left) Lys244 as an active residue (AIR). Mass centers of Cc are colored as a function of intermolecular energy (Einter) according
to the scales represented in their corresponding panels
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binding energy in the three clusters (Supplementary
Table S2). However, the concave cluster was more ener-
getically favored than the convex clusters, mainly due to a
lower electrostatic energy (Eelec). Nevertheless, convex
clusters presented lower AIRs violations than the concave
cluster.
Furthermore, to study the role of the 14-3-3ε C-
terminal tails in the interaction, a docking computation
was also performed including Lys244 (located in the C-
terminal tail), as an active residue. This computation
showed an increase in the number of solutions locating Cc
in the concave binding site of 14-3-3ε (Fig. 6, right panel),
suggesting that the C-terminal tails contribute to the
entrance of Cc into the concave groove of 14-3-3ε.
Clustering analysis exhibited three clusters of solutions
presenting Cc bound to the concave site of 14-3-3ε, and
only one displaying Cc bound to the convex site (Sup-
plementary Figure S8b). Again, electrostatic interactions
constituted the major contribution in all clusters, concave
site clusters displaying lower energies because of their
Eelec term (Supplementary Table S2).
Structural models of Cc / 14-3-3ε FL complex were
obtained for computations excluding and including
(Supplementary Figure S8c and d, respectively) Lys244 as
an active residue of 14-3-3ε. For this, the best two com-
plexes with minimal Einter at each binding site of 14-3-3ε
were selected from each computation. Both structural
models present a Cc molecule located in the concave
groove of 14-3-3ε, contacting at least one of the C-
terminal tails of 14-3-3ε dimer. A second Cc molecule is
placed at the convex side of 14-3-3ε, specifically at the rim
of the dimerization surface thereby binding both 14-3-3
monomers. In addition, the two Cc molecules from both
computations present their heme clefts oriented to 14-3-
3ε, according to NMR data.
Discussion
Due to the apoptosis significance in multicellular
organisms, its regulation relies on a subtle balance
between inhibition and activation pathways. In fact, sig-
naling cascades convert continuous stimuli in an all-or-
none response to avert physiological fluctuations to trig-
ger a response accidentally35. Feedbacks are needed to
lead response ultra-sensitivity: a large stimulus is required
to trigger a response, which changes dramatically within a
narrow range of stimulus intensity. During homeostasis,
apoptotic factors remain inhibited, either blocked by
other proteins or sequestered in a particular cell com-
partment. Along apoptosis, several apoptotic factors are
released from the mitochondria to the cytosol. Among
these factors is Cc, which promotes the apoptosome
assembly through its association with Apaf-1, thereby
initiating the caspase cascade6. On the other hand, pro-
survival pathways, as the inhibition of Apaf-1 by 14-3-
3ε25, reduce the sensitivity to the apoptosis signaling
network.
Therefore, interactions between pro-apoptotic and pro-
survival proteins, such as that between Cc and 14-3-3ε,
are of particular relevance as they provide additional
regulation loops. In this study, we have shown that Cc
interacts with 14-3-3ε in the cytosol under apoptotic
conditions, preventing the binding of 14-3-3ε to a specific
site in Apaf-1. Hence, this interaction could be capable of
regulating caspase activity. Indeed, Cc enhanced caspase
activation in presence of 14-3-3ε inhibitor and a trun-
cated, constitutive form of Apaf-1 unable to bind the
hemeprotein. Thus, Cc plays a double role in the activa-
tion of caspase cascade directly by interacting with Apaf-
1, and indirectly by blocking 14-3-3ε thereby releasing
Apaf-1. This double role enables Cc to inhibit pro-survival
pathways while apoptotic routes have been triggered
(Fig. 4).
Further phenomena modulate the cell fate signaling,
including protein phosphorylation events, as those which
regulate Cc functions, including its ability to activate
caspases36–40. In addition, such a phosphorylation
enhances the inhibition of Apaf-1 by 14-3-3ε25, making
caspase activation less sensitive to Cc. In fact, activation of
MAPK cascade favors the Apaf-1 inhibition by 14-3-3ε.
Similarly, the phosphomimetic Apaf-1 mutant is more
susceptible to 14-3-3ε-dependent inhibition, which con-
sequently becomes less sensitive to the presence of Cc.
Hence, this phosphorylation of Ser268 in Apaf-1 may
attenuate the effect of Cc release when caspase activation
is undesirable (Fig. 4).
Cc does lack the consensus sequence which 14-3-3ε
usually recognizes in its various targets. Our biophysical
analysis has revealed that two molecules of Cc can interact
with 14-3-3ε at two different sites: the groove of 14-3-3ε
where its targets bind, and the convex side of the dimer.
Additionally, the data herein suggest that flexible C-
terminal 14-3-3ε may recognize Cc without being essen-
tial for the binding. These tails are flexible and mostly
unstructured, although MD trajectories indicate the pre-
sence of residual helical elements. Moreover, NMR data
show that Cc recognizes 14-3-3ε by residues surrounding
the heme cleft, as reported for other interactions involving
the hemeprotein31–33.
In summary, Cc is revealed as a double Apaf-1 activator
via two mechanisms: by directly binding to the apoptosis
factor and impairing its inhibition by 14-3-3ε. Indeed,
such a cooperative behavior of Cc, triggering effector
pathways while modulating feedbacks loops make cell
response ultrasensitive to its release. The analysis of the
various additional interactions of Cc during the onset of
programmed cell death recently unveiled may confirm if
this conclusion can be extended as a general mechanism
by which Cc triggers apoptosis9–12,41.
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Materials and methods
Cell cultures
HeLa and Human Embryonic Kidney 293T (HEK293T)
cells were cultured in Dulbecco’s modified Eagle’s med-
ium (DMEM), supplemented with 10% heat-inactivated
fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL
penicillin, 100 μg/mL streptomycin, and maintained at 37
°C in a humidified 5% CO2 atmosphere.
For caspase-3 assays, 4.5 × 106 HEK293T cells were
cultured in 140 mm Petri dishes in DMEM containing
FBS until 70% confluence was reached, and cells were
then kept in DMEM without FBS for 4 h. In some
experiments (indicated in the main text) cells were treated
with 50 ng/mL phorbol-12-myristate-13-acetate (PMA,
Sigma-Aldrich) or treated with the same volume of
DMSO for 120min.
shRNA knockdown
In order to knockdown 14-3-3ε expression in
HEK293T cells, a construct containing the shRNA
sequence (5′-GATCCCCTGTTCAA-
TACTGCTGATTATTCTCCTTCAAGAGAGGAGAA-
TAATCAGCAGTATTGAACATTTTTA-3′) was cloned
into a pSUPER vector using BgIII–HindIII restriction
sites. An empty pSUPER vector was used as a control.
Cells were transfected with the corresponding pSUPER
plasmid by calcium phosphate method, as described
elsewhere42. Transfected cells were selected by adding
puromycin (1.5 μg/mL) to the culture medium. Four days
after transfection, cells were collected and cytosolic
extracts were obtained.
Subcellular fractionation and extract preparation
For immunoprecipitation assays, 6 × 106 HeLa cells
were seeded in 140mm Petri dishes and treated with an
apoptosis inducing agent (20 μM camptothecin, CPT) for
4 h. HeLa cells were fractionated into cytosolic, mem-
brane/organelles and nuclear fractions using a ProteoEx-
tract Subcellular Proteome Extraction Kit (Calbiochem)
following the manufacturer’s indications. The purity of
subcellular fractions obtained was verified by western blot
analysis, using anti-α-tubulin and anti-COX IV for
detecting cytosol and mitochondria, respectively.
For caspase-3 activity assays, cytosolic extracts were
obtained from HEK293T cells as previously described
with briefly modifications43. Briefly, cells were trypsinized
and collected by centrifugation (5 min at 1500×g) and
washed twice with phosphate buffer saline (PBS) and once
with Cellular Extract Buffer (CEB, 20 mM HEPES at pH
7.5, 10 mM KCl, 1.5 mM MgCl2, 1 mM Na-EDTA, 1 mM
EGTA, 1 mM dithiothreitol [DTT], 100 μM PMSF). Two
volumes of CEB were added to cells, and they were
incubated for 15min on ice, allowing the hypotonic swell
of cells. The cells were then disrupted by 20–25 strokes
with a Douncer homogenizer and lysates were centrifuged
at 15,000×g for 15 min at 4 °C to remove organelles.
Immunoprecipitation
Cytosolic fractions from subcellular fractionation of
control and CPT-treated HeLa cells were used to immu-
noprecipitate Cc. Quantity of 300 μg of cytosolic samples
were incubated with 50 μL Sepharose 6B (Sigma-Aldrich)
for 2 h at 4 °C under agitation as a pre-clearing step to
reduce non-specific binding. Samples were centrifuged
and 20 μL of rabbit anti-human cytochrome c (Cc) were
added to supernatants and incubated overnight at 4 °C
under rotation. As a negative control, 300 μg of cytosolic
lysates were incubated with 1 μg of anti-mouse IgG under
the same conditions. Afterwards, 50 μL Protein A
Sepharose (GE Healthcare) was added to each lysate for 4
h at 4 °C under rotation. The protein-Sepharose com-
plexes were washed extensively, collected by centrifuga-
tion and boiled in freshly prepared reducing loading
buffer. Controls including 30 μg of cytosolic lysates were
run concurrently with the immunoprecipitated (IP) sam-
ples in the western blot assays.
Apaf-1 immunoprecipitation was performed from total
non-treated and PMA-treated lysates. Apaf-1 IP samples
were analyzed by western blot using a Phos-tagTM SDS
PAGE (Wako) — which reduce the electrophoretic
mobility of phosphorylated proteins.
Antibodies
Rabbit anti-human Cc serum was obtained after
immunizing male rabbits with full length recombinant Cc
suspended in a 0.85% solution of NaCl (20 mg/mL). The
suspension was then incorporated into an equal amount
of complete (Freund) adjuvant obtained from Difco (BD
Biosciences, US). Mouse monoclonal anti-α-Tubulin
(catalogue number T8328), as well as secondary horse-
radish peroxidase (HRP)-conjugated anti-mouse IgG
(catalogue number A4416), rabbit polyclonal anti-14-3-3ε
(catalogue number SAB4503100), and anti-rabbit IgG
(catalogue number A0545) were obtained from Sigma-
Aldrich. Rabbit polyclonal antibody to cytochrome c
oxidase subunit IV (COX IV) was from Abcam (catalogue
number ab16056). Mouse monoclonal anti-Apaf-1 (cata-
logue number sc-135836) was obtained from Santa Cruz
Biotechnology, INC. Mouse monoclonal anti-
phosphoserine (Millipore clone A4) was obtained from
Merck.
Western blot analysis
For the immunoblot detection of Cc, α-Tubulin, COX
IV, and 14-3-3ε in the subcellular fractions or IP sam-
ples, protein content was measured using the DCTM
protein assay (Bio-Rad Laboratories, US). Proteins were
resolved by sodium dodecyl sulphate-polyacrylamide gel
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electrophoresis (SDS-PAGE) in 12% gels and then
transferred onto polyvinylidene fluoride (PVDF) mem-
branes (EMD Millipore) using a Mini Trans-Blot elec-
trophoretic transfer cell (Bio-Rad). Membranes were
blocked in 5% non-fat dry milk in PBS with Tween-20
(TPBS) and immunoblotting was performed with pri-
mary antibodies. HRP-conjugated secondary antibodies
were used for detection. The immunoreactive bands
were detected using Amersham ECL Plus Western
Blotting Detection Reagents (GE Healthcare Life
Sciences).
Cloning, expression, and purification of recombinant
proteins
Cc was expressed in Escherichia coli BL21 (DE3) strain
as previously described32. First, 25 mL Luria-Bertani (LB)
medium, supplemented with 100 μg/mL ampicillin, were
grown overnight at 37 °C under agitation. Volume of 2.5
mL of pre-culture was used to inoculate 2.5 L of LB
medium. The culture was incubated at 30 °C under agi-
tation for 24 h. Then, cells were centrifuged at 6000 r.p.m.
for 10 min in an Avanti J-25 centrifuge (Beckman Coul-
ter). Following this, cells were re-suspended in 1.5 mM
borate buffer (pH 8.5), sonicated for 4 min and, finally,
cellular debris was eliminated by centrifugation (20,000 r.
p.m. for 30min). For NMR measurements, 15N-labeled Cc
was produced in minimal media with 15NH4Cl as a unique
nitrogen source. Cc purification was carried out by ionic
chromatography with a carboxy-methylcellulose matrix.
Fractions containing Cc were concentrated in an Amicon
(3 kDa cutoff) until correct concentration was achieved.
14-3-3ε full length (14-3-3ε FL) was cloned into the
pET-28a vector under the T7 promotor using NdeI –
XhoI restriction sites and containing a N-terminal hex-
ahistidine tag. For cloning, the following primers were
used: 5′-AGCCATATGATGGATGATCGAGAGGAT-3′
and 5′-GTGCTCGAGTCATTCCTGATTTTCGTC-3′.
The 14-3-3ε core was cloned with a Stop codon intro-
duced after residue at position 233. The primers used for
this mutagenesis were 5′-ACACTATGGACTTCATA-
GATGCAGGGTGACGGT-3′ and 5′-
ACCGTCACCCTGCATCTATGAAGTCCATAGTGT-
3′. 14-3-3ε FL D21K, K50E, S59E, E92K, D99K, and
S187D mutants were obtained from Mutagenex Inc.
(USA). The expression of 14-3-3ε species were performed
in the E. coli BL21 (DE3) strain. Cultures were grown in
LB medium at 37 °C until an O.D.600 nm of 0.6–0.8 was
reached. Protein expression was induced by adding 1mM
isopropyl-β-D-1-thiogalactopyranoside (IPTG) and cul-
tures were grown for 24 h at 30 °C. The cells were col-
lected by centrifugation and re-suspended in 20mM Tris-
HCl (pH 8), 800mM NaCl, 10 mM imidazole. Cells were
then broken by sonication and insoluble debris was
removed by centrifugation, as indicated above. 14-3-3ε
species were purified by affinity chromatography, using a
Ni Sepharose 6 Fast Flow (GE Healthcare) column and an
imidazole gradient ranging from 10mM to 300mM imi-
dazole. Protein containing fractions were concentrated in
an Amicon (3 kDa cutoff) until the desired proper protein
concentration was reached.
Proteins were dialyzed against 10 mM sodium phos-
phate (pH 7.4) buffer for ITC measurements or 5 mM
sodium phosphate (pH 6.3) buffer for NMR titrations. For
caspase assays, protein was dialyzed against 20 mM
HEPES (pH 7.5) buffer.
14-3-3ε C-terminal peptide (14-3-3ε234-255) was pur-
chased from Genosphere Biotechnologies (France).
Apaf-1ΔWD40 S268D and S268A mutants were obtained
by mutagenic PCR from pET28a-Apaf-1ΔWD40, using 5′-
ACCAGAGACAAGGATGTTACAGATT-3′ and 5′-
AATCTGTAACATCCTTGTCTCTGGT-3′ primers for
the S268D mutant and 5′-ACCAGAGA-
CAAGGCTGTTACAGATT-3′ and 5′-AATCTGTAA-
CAGCCTTGTCTCTGGT-3′ primers for the S268A
mutant. All Apaf-1ΔWD40 species were expressed as pre-
viously described with small modifications6. Protein
expression was carried out in E. coli BL21 (DE3) at 20 °C
after induction with 1 mM IPTG. Cells were broken by
freeze/heat cycles and cellular debris was removed by
centrifugation. The soluble fraction was purified by affi-
nity chromatography (His·Trap column, GE Healthcare)
followed by anionic-exchange (Hi·Trap column, GE
Healthcare). Recombinant caspase-9 was expressed in E.
coli BL21 (DE3) at 30 °C and purified as indicated above
for Apaf-1ΔWD40. Protein quantification was assessed
using the Bradford protein assay44.
Caspase-9 assays
Caspase-9 activity was measured as previously descri-
bed6. Recombinant Apaf-1ΔWD40 species and 14-3-3ε FL
were mixed in buffer (40 mM HEPES, pH 7.5, 20 mM KCl,
1 mM DTT) to a final concentration of 100 nM and 1 μM,
respectively. Cc was added at different concentrations
(ranging from 1 to 5 μM). After incubation for 15min at
room temperature, recombinant caspase-9 was added to a
final volume of 100 μL and final concentration of 500 nM.
After incubation for another 15min at 37 °C, the caspase-
9 substrate LEHD peptide coupled to 7-amino-4-
trifluoromethylcoumarin (Ac-LEHD-AFC, TOCRIS) was
added at a final concentration of 50 μM. The increase in
fluorescence resulting from Ac-LEHD-AFC cleavage was
determined in a Cary Eclipse (Varian) fluorescence spec-
trophotometer, using an excitation wavelength of 390 nm
and an emission wavelength of 510 nm. Each experi-
mental data were the mean ± SD value of at least three
independent measurements.
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Caspase-3 assays
In vitro caspase-3 assays were performed as formerly
described with slight changes45. Recombinant Cc and 14-
3-3ε FL were mixed and incubated with 100 μg of cyto-
solic HEK293T cells extracts for 60min at 37 °C in 10mM
HEPES (pH 7.5) buffer, supplemented with 25 mM KCl,
200 μM DTT, 200 μM dATP. After incubation, 10 mM
HEPES (pH 7.5), 50 mM NaCl, 40 mM β-glyceropho-
sphate, 2 mM MgCl2, 5 mM EGTA, 0.1 mgmL
−1 bovine
serum albumin, and 0.1% (w/v) 3-[3-cholamidopropyldi-
methylammonio]-1-propanesulfonate (CHAPS) buffer
was added to a final volume of 200 μL, supplemented with
40 μM of acetyl-DEVD-7-amino-4-methylcoumarin (Ac-
DEVD-AMD, Enzo Life Sciences), a fluorescent substrate
specific to caspase-3/7. The increase in fluorescence
resulting from Ac-DEVD-AMC cleavage was determined
in a Cary Eclipse (Varian) fluorescence spectro-
photometer, using an excitation wavelength of 360 nm
and an emission wavelength of 460 nm. To compare the
effect of 14-3-3ε in different types of extracts, values for
caspase-3 activity before adding recombinant 14-3-3ε FL
were normalized. Each experimental data were the mean
± SD value of at least three independent measurements.
ITC measurements
All ITC experiments were performed using an Auto-
ITC200 (MicroCal-Malvern Instruments, UK) at 25 °C by
titrating 14-3-3ε species and 14-3-3ε peptides with Cc.
The reference cell was filled with distilled water. The
experiments consisted of 2-μL injections of 300 μM Cc
solution in 10 mM sodium phosphate buffer (pH 7.4) into
the sample cell, initially containing 20 μM 14-3-3ε solu-
tion in the same buffer. All solutions were degassed before
titrations were performed. Titrant was injected at appro-
priate time intervals to ensure the thermal power signal
returned to the base line prior to the next injection. To
achieve homogeneous mixing in the cell, the stirring
speed was maintained constant at 750 r.p.m. The data,
specifically the heat per injection normalized per mole of
injectant vs. the molar ratio, were analyzed with Origin 7.0
(OriginLab Corp.). Calibration and performance tests of
the calorimeter were carried out conducting CaCl2-EDTA
titrations with solutions provided by the manufacturer.
Control experiments (Cc solution injected into buffer)
were performed in order to assess potential unspecific
heat effects.
NMR spectroscopy
NMR titration of reduced Cc with 14-3-3ε FL was fol-
lowed by 1D 1H and 2D [1H, 15N] HSQC spectra on a
Bruker Avance 700MHz at 25 °C. 50 μM of reduced, 15N-
labelled Cc in 5 mM sodium phosphate buffer (pH 6.3)
was titrated with unlabeled 14-3-3ε in the same buffer.
0.1M sodium ascorbate and 10% D2O were added in
order to ensure the redox state remained constant and to
adjust the lock signal, respectively. Water signal was
suppressed according to the WATERGATE solvent sup-
pression method46. The interaction of reduced Cc with
14-3-3ε234-255 was performed on a Bruker Avance 600
MHz in the same way as previously described for the
titration. Data were processed using TopSpin NMR
2.0 software (Bruker). Line broadening and chemical-shift
perturbation analysis were performed using Sparky 3
NMR Assignment Program (T.D. Goddard and D.G.
Kneller, University of California – San Francisco, US).
CSP titration curves were fitted using the one-site binding
model.
To fluorinate the Lys244 side chain of 14-3-3ε234-255,
the bioconjugation reaction was performed with 5-
fluoroindole compound (Sigma) as previously descri-
bed47. 500 μM acetylated 14-3-3ε234-255 peptide was
mixed with 2 mM formaldehyde solution (37% w/w) and
with 6 mM 5-fluoroindole for 24 h at 30 °C. Then, the
sample was dialyzed against 10 mM sodium phosphate
(pH 6.3) buffer overnight. Proper folding of 14-3-3ε234-255
before and after the reaction was checked by 1D 1H
spectra, and the interaction with Cc was followed
recording 1D 19F experiments at 25 °C on a Bruker
Avance 600MHz.
Analytical ultracentrifugation
Sedimentation velocity experiments of 14-3-3ε FL WT,
D21K, K50E, S59E, E92K, D99K, and S187D were per-
formed at 20 °C in an Optima XL-A Analytical Ultra-
centrifuge (AU, Beckman Instruments) with an AN50-Ti
rotor. These experiments were carried out at 45,000 r.p.m.
with 400-μL samples at 37 μM in 5mM sodium phos-
phate buffer (pH 6.3) loaded into double sector cells.
Radial scans at 280 nm were taken every 10min and the
sedimentation coefficient distribution was calculated by
least squares boundary modeling of the sedimentation
velocity data using the programme SEDFIT. The experi-
mental coefficients were converted to standard conditions
(s20,w).
Molecular dynamic computations
Molecular dynamics (MD) computations were carried
out using the AMBER 12 package and the AMBER-2003
force field. For the 14-3-3ε234-255 peptide simulation, an
unfolded and outspread conformation was used as initial
coordinates. After 100 ns of simulation, the closest
structure to the average from the last 40 ns of this com-
putation was attached to the crystallographic structure of
14-3-3ε (PDB: 2BR9)15 at the C-terminal of both mono-
mers. The resulting structure was used as the initial
coordinate for the full length protein in the MD compu-
tation. With the aim to promote the opening of 14-3-3ε
FL and to produce an open conformation, both consensus
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peptide ligands for 14-3-3 proteins included in the crys-
tallographic structure were removed from the initial
coordinates.
All simulations were carried out under periodic
boundary conditions using an orthorhombic cell geo-
metry (minimum distance between protein and cell faces
was initially set to 10 Å) and PME electrostatics were set
with the Ewald summation cutoff at 9 Å. Sodium counter-
ions were added to neutralize the charges of the system.
The structures were solvated with SPC water molecules.
Afterwards, solvent and counter-ions were subjected to
2000 steps of energy minimization followed by 300 ps
NPT-MD computations using isotropic molecule position
scaling and a pressure relaxation time of 1 ps at 298 K.
The density of the system reached a plateau during the
first 150 ps. Then, the whole system was energy mini-
mized and submitted to NVT MD computations at 298 K.
The SHAKE algorithm48 was used to constrain bonds
involving hydrogen atoms. The PTRAJ module of AMBER
was used for trajectory analysis.
NMR-driven docking
Restrained docking calculations were performed with
the High Ambiguity Driven Docking approach (HAD-
DOCK)49–51, using the 3ZCF.pdb structure of Cc and the
resulting open model of 14-3-3ε FL from MD calcula-
tions. Dielectric constant was set as distance-dependent.
Scaling of ambiguous interaction restraints (AIRs) were
fixed to 0.1 for rigid body and to 1.0 for both semi-flexible
simulated annealing and final refinement. AIRs for the
docking simulation were generated using standard cri-
teria. Random exclusion of AIRs was not employed. Cc
residues labeled as active were those showing 1H ΔΔν1/
2Binding ≥ 59.2 Hz and a solvent accessibility larger than
50% calculated with NACCESS. These active residues
were Gln16, Gln42, Ser47, Ala50, Gly77, Lys79, Ile81, and
Val83. Cc residues located at <4 Å from the active ones
and showing high-solvent accessible surface (>50%) were
labeled as passive residues. 14-3-3ε residues labeled as
active were those whose mutation resulted in the
impairment of one of the Cc-binding sites: Asp21, Lys50,
Ser59, and Glu92. 14-3-3ε residues located at <4 Å from
the active ones and showing high-solvent accessible sur-
face (>50%) were labeled as passive residues. For each run,
10,000 rigid-body solutions were generated by energy
minimization. The 1000 structures with the lowest AIRs
energies were subjected to semi-flexible simulated
annealing. The first 500 structures were submitted to a
final refinement in explicit water. The 500 best structures
were analyzed using standard criteria. AIR violations were
calculated using as reference the solution with best
HADDOCK score. Structures were represented using
UCSF Chimera52.
Dynamic light scattering measurements
Dynamic light scattering experiments were performed
to evaluate the dimerization state of 14-3-3ε FL WT and
D21K, K50E, S59E, E92K, D99K, and S187D mutants, in 5
mM sodium phosphate at pH 6.3. DLS experiments on
0.1 mg/mL of each 14-3-3ε species were conducted at 25 °
C in a Zetasizer Nano ZS (Malvern Instruments).
Statistical analysis
Statistical analysis was performed using GraphPad
Prism 7 Software and experimental data of at least three
independent measurements. Statistical significance was
estimated using Student's t-test. A p-value of <0.0002 was
considered significant.
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